Entity
Description
  • Value proposition

    A Path to SuperCellsTM Therapies

    GC Therapeutics Inc. (GCTx) uses synthetic biology to program patient-derived stem cells into any cell type with best-in-class efficiency (up to 10X), speed (up to 100X) and scalability. We dictate cells fates in a single step and have validated cells for many applications. We have also developed SuperCellsTM by tailoring cells for specific diseases.

    The core technology of GCTx was conceived, invented and perfected in Professor George Church’s lab at Harvard Medical School. We are a group of passionate biologists and tissue engineers whose goal is to bring this breakthrough approach to patients.

  • GC Therapeutics

    Discover GC Therapeutics, a pioneer in scalable, cutting-edge cell therapies designed to revolutionize treatment across a broad range of therapeutic areas.

  • https://www.gc-tx.com/
Catalyst interactions
Catalyst TypeTweets Articles
Amgen
Amgen
Biotechnology, Biotechnology Research
Amgen
Biotechnology, Biotechnology Research
Other

20 Dec 2019


Social network dynamics
Similar entities
BETA
Loading...
Loading...